Tumours
Tumours

Thyroid

Description

The Thyroid Cancer Group is dedicated to thyroid cancer, collaborating with endocrinologists and oncologists to carry out clinical studies.

Main Achievements

In accordance with the recommendations from the EORTC Scientific Advisory Council (SAC) regarding the need to accurately represent the group’s interests and focus, the EORTC Endocrine Tumour Group (EnTG) will officially be renamed the EORTC Thyroid Cancer Group (TCG) effective 06 November 2024.

This name change aligns with the group’s mission to reduce the impact of thyroid cancer through collaboration with endocrinologists and oncologists in clinical studies.

The group will concentrate on thyroid cancer across various tumor types and stages, addressing diagnostic and staging techniques, translational research, treatment modalities, and quality of life.

Research Group

Group documents
  • Chair

    Marek Dedecjus

    Maria Sklodowska-Curie National Research Institute of Oncology

    Warsaw, Poland

  • Secretary

    Romana Netea-Maier

    Radboud University Medical Center

    Nijmegen, Netherlands

  • Treasurer

    Paula Soares

    Faculty of Medicine of the University of Porto & Institute for Research and Innovation in Health

    Porto, Portugal

Steering committee

  • L. Locati - Pavia, IT

    Istituti Clinici Scientifici Maugeri

  • M. Dedecjus - Warsaw, PL

    Maria Sklodowska-Curie National Research Institute of Oncology

  • P. Soares - Porto, PT

    Faculty of Medicine of the University of Porto & Institute for Research and Innovation in Health

  • C. De La Fouchardière - Marseille, FR

    Institut Paoli-Calmettes

  • R. Netea-Maier - Nijmegen, NL

    Radboud University Medical Center

Committee(s)Close Committee(s)
Go to Top